A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Several professionals stated the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to penalties, legal action or prison.
Platform Response and Material Elimination
According to the social media company, the service has taken down problematic material and banned related keywords and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After minutes of joining one group, a seller shared contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.
Product Details and Pricing
Within these communities, posts show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram stated it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious medical dangers”.
